In future, patients should have access to innovative medicines on the day the product is authorised by Swissmedic («Day 0»).
is the pharmaceutical industry's share of Swiss goods exports, making it the country's most important export sector by far.
People in Switzerland benefit from access to high-quality healthcare provision. However, there is still a need for action and improvement in various areas.
The pharmaceutical industry in Switzerland will also need attractive framework conditions in future, including legal certainty, open export markets and the availability of labour.
show more articles
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.
Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.
Information on our key figures and activities in the financial year 2024
read more
Introducing Interpharma
read more
More about the tasks and overriding aims of Interpharma
read more
Contact us
read more
Latest information and media contacts for media representatives
read more
Download